Assess mast cell burden in systemic mastocytosis using serum tryptase level, bone marrow mast cell percentage, and WHO B and C findings to classify indolent vs advanced disease.
Assess mast cell burden in systemic mastocytosis using serum tryptase level, bone marrow mast cell percentage, and WHO B and C findings to classify indolent vs advanced disease
Each component has a specific meaning:
Note: Interpret the mastocytosis burden result against the thresholds and context described above.
Enter the serum tryptase level, bone marrow mast cell percentage, WHO B, C findings for the scenario you are assessing. Assess mast cell burden in systemic mastocytosis using serum tryptase level, bone marrow mast cell percentage, and WHO B and C findings to classify indolent vs advanced disease. Use the mastocytosis burden result to inform your calculation.